Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes More
Two types of vaccines for preventing and treating allergic diseases including atopic dermatitis, allergic asthma, allergic rhinitis, allergic conjunctivitis, and urticaria. More
These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Nov 2010 - 1517 pages - $1,495
May 2011 - 34 pages - $500
Dec 2010 - 48 pages - $500
May 2011 - 39 pages - $500
Enjoy Life Natural Brands Case Study: capitalizing on rising consumer interest in anti-allergy foods
Aug 2009 - 11 pages - $295
Jul 2010 - 180 pages - $750
May 2011 - 35 pages - $125
Feb 2011 - 28 pages - $125
Nov 2010 - 37 pages - $600
Your selection
- Therapeutic target
- Allergy del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us